bimekizumab,Adalimumab
ucb pharmaceuticals,abbvie
[]
ucb showcases commitment to advancing care in immune-mediated inflammatory diseases with 23 abstracts at eular 2023 #pharma #lifesciences #biotech #clinicalresearch #news #pharmiweb 
News from across the pharmaceutical and biotech industry from PharmiWeb https://t.co/ea1b58MZYg